Arvest Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417K Buy
6,185
+4
+0.1% +$266 0.05% 151
2026
Q1
$388K Buy
+6,181
New +$430K 0.05% 149

Other funds holding DXCM

Arvest Investments's DXCM Position: Q2 2026 in Review

Arvest Investments increased its DexCom (DXCM) stake by 0.06% in Q2 2026, buying an estimated $266 and bringing the position to 6,185 shares worth $417K. The position accounts for 0.05% of the portfolio, ranked #151.

Arvest Investments first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Arvest Investments held 6,185 shares of DexCom worth $417K as of Q2 2026.
  • Arvest Investments bought 4 DexCom shares in Q2 2026, an estimated $266.
  • DexCom made up 0.05% of Arvest Investments's portfolio in Q2 2026, its #151 holding.
  • Arvest Investments first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.